Inizio has announced that it has appointed Colin Stanley as its new chief commercial officer.
Stanley brings over 30 years of experience in clinical development and commercialisation to the role, which he takes on after most recently serving as president of Inizio Advisory.
“Over the past 12 months, Colin has played a key role in shaping our enterprise commercial model and delivering impact through our connected suite of capabilities,” said Inizio’s chief executive officer, Paul Taaffe.
Prior to Joining Inizio, Stanley was president of Ashfield Advisory and held positions of increasing responsibility over almost 18 years at ICON, culminating in his role as president of ICON’s Functional Services group.
During his time at ICON, Stanley served as chief operating officer and later president of the company’s global DOCS business.
He was also previously vice president of ICON’s Asia-Pacific clinical operations, director of its US clinical operations and director of continuous process improvement, after initially holding project manager and associate director positions at the company.